Decoding 6 Analyst Evaluations For Pacira BioSciences
Decoding 6 Analyst Evaluations For Pacira BioSciences
解读6位分析师对pacira biosciences的评估
The standing of Pacira BioSciences...Across the recent three months, 6 analysts have shared their insights on Pacira BioSciences (NASDAQ:PCRX), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月中，6位分析师分享了他们对pacira biosciences（纳斯达克：PCRX）的见解，表达了从看好到看淡的各种观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $21.17, a high estimate of $39.00, and a low estimate of $15.00. Highlighting a 2.31% decrease, the current average has fallen from the previous average price target of $21.67.
分析师分析的12个月价格目标提供了洞察，平均目标为21.17美元，高估为39.00美元，低估为15.00美元。当前平均价格目标与之前的21.67美元相比下降了2.31%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级：全面解析
The standing of Pacira BioSciences...
通过对最近...
登录免费看全文
登录/注册
资讯热榜
更新时间